Detalles de la búsqueda
1.
Predictive factors and oncological outcomes of pathological T3a upstaging in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
Jpn J Clin Oncol
; 54(2): 160-166, 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37840320
2.
Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions.
Int J Urol
; 31(1): 73-81, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37798866
3.
Surgical and functional outcomes of repeat robot-assisted laparoscopic partial nephrectomy compared with repeat open partial nephrectomy.
Int J Urol
; 31(4): 355-361, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38146740
4.
Real-world efficacy and safety of cabozantinib following immune checkpoint inhibitor failure in Japanese patients with advanced renal cell carcinoma.
Jpn J Clin Oncol
; 53(10): 977-983, 2023 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37519060
5.
Impact of sex on prognosis in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors.
Jpn J Clin Oncol
; 53(7): 611-618, 2023 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37002188
6.
Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up.
Jpn J Clin Oncol
; 52(7): 785-790, 2022 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35373823
7.
Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.
Jpn J Clin Oncol
; 52(10): 1208-1214, 2022 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35780441
8.
Surgical and functional outcomes of robot-assisted laparoscopic partial nephrectomy for renal cell carcinoma in adolescents and young adults: a propensity score matching study.
Int J Clin Oncol
; 27(10): 1624-1631, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35877053
9.
Prognostic Impact of Trial-Eligibility Criteria in Patients with Metastatic Renal Cell Carcinoma.
Urol Int
; 106(4): 368-375, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34515259
10.
Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data.
Jpn J Clin Oncol
; 51(5): 793-801, 2021 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33324983
11.
Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy.
Jpn J Clin Oncol
; 51(12): 1744-1750, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34487184
12.
Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus.
Jpn J Clin Oncol
; 51(5): 819-825, 2021 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33558883
13.
Modest efficacy of nivolumab plus ipilimumab in patients with papillary renal cell carcinoma.
Jpn J Clin Oncol
; 51(4): 646-653, 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33212488
14.
Prognostic impact of systemic therapy change in metastatic renal cell carcinoma treated with cytoreductive nephrectomy.
Jpn J Clin Oncol
; 51(2): 296-304, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32989464
15.
Association of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma.
Jpn J Clin Oncol
; 51(12): 1751-1756, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34492101
16.
Preoperative autologous blood donation for kidney transplant and end-stage renal disease patients: A single-center study.
Transfus Apher Sci
; 60(4): 103149, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34148766
17.
Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma.
Clin Exp Nephrol
; 25(6): 674-682, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33641007
18.
Efficacy of nivolumab versus molecular-targeted therapy as second-line therapy for metastatic renal cell carcinoma: Real-world data from two Japanese institutions.
Int J Urol
; 28(1): 99-106, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159426
19.
Clinical outcomes of repeat partial nephrectomy compared to initial partial nephrectomy of a solitary kidney.
Int J Clin Oncol
; 25(6): 1155-1162, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32065298
20.
Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution.
Int J Clin Oncol
; 25(5): 892-898, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32048086